Similar articles

• Antiarrhythmic actions of coronary vasodilator agents papaverine, dioxyline and verapamil.

  Hanna C, Schmid JR. Hanna C, et al. Arch Int Pharmacodyn Ther. 1970 Jun;185(2):228-33. Arch Int Pharmacodyn Ther. 1970. PMID: 5473785 No abstract available.
• A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol.

  Schmid JR, Hanna C. Schmid JR, et al. J Pharmacol Exp Ther. 1967 May;156(2):331-8. J Pharmacol Exp Ther. 1967. PMID: 4381702 No abstract available.
• The actions of verapamil on experimental arrhythmias.

  Rodrigues-Pereira E, Viana AP. Rodrigues-Pereira E, et al. Arzneimittelforschung. 1968 Feb;18(2):175-9. Arzneimittelforschung. 1968. PMID: 5695375 No abstract available.
• [Current state and goals of the clinico-pharmacological evaluation of anti-arrhythmia and anti-angina agents].

  Mazur NA. Mazur NA. Kardiologiia. 1982 May;22(5):42-7. Kardiologiia. 1982. PMID: 6124650 Review. Russian. No abstract available.
• Clinical pharmacology of calcium entry blockers.

  Bianchi CP. Bianchi CP. Cardiovasc Clin. 1983;14(1):123-8. Cardiovasc Clin. 1983. PMID: 6311420 Review. No abstract available.